{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:00:43Z","timestamp":1792155643880,"version":"4.4.0"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) lockdown dramatically changed people\u2019s lifestyles. Diet, physical activity, and the PNPLA3 gene are known risk factors for non-alcoholic fatty liver disease (NAFLD). Aim: To evaluate changes in metabolic and hepatic disease in NAFLD patients after the COVID-19 lockdown. Three hundred and fifty seven NAFLD patients were enrolled, all previously instructed to follow a Mediterranean diet (MD). Anthropometric, metabolic, and laboratory data were collected before the COVID-19 lockdown in Italy and 6 months apart, along with ultrasound (US) steatosis grading and information about adherence to MD and physical activity (PA). In 188 patients, PNPLA3 genotyping was performed. After the lockdown, 48% of patients gained weight, while 16% had a worsened steatosis grade. Weight gain was associated with poor adherence to MD (p = 0.005), reduced PA (p = 0.03), and increased prevalence of PNPLA3 GG (p = 0.04). At multivariate analysis (corrected for age, sex, MD, PA, and PNPLA3 GG), only PNPLA3 remained independently associated with weight gain (p = 0.04), which was also associated with worsened glycemia (p = 0.002) and transaminases (p = 0.02). During lockdown, due to a dramatic change in lifestyles, half of our cohort of NAFLD patients gained weight, with a worsening of metabolic and hepatologic features. Interestingly, the PNPLA3 GG genotype nullified the effect of lifestyle and emerged as an independent risk factor for weight gain, opening new perspectives in NAFLD patient care.<\/jats:p>","DOI":"10.3390\/nu14030556","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:00:56Z","timestamp":1643320856000},"page":"556","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-9233","authenticated-orcid":false,"given":"Felice","family":"Cinque","sequence":"first","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-9307","authenticated-orcid":false,"given":"Annalisa","family":"Cespiati","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6958-927X","authenticated-orcid":false,"given":"Rosa","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-6051","authenticated-orcid":false,"given":"Andrea","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"},{"name":"Unit of Gastroenterology and Endoscopy, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Maffi","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Alletto","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Colavolpe","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Francione","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Oberti","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Fatta","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bertelli","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-5778","authenticated-orcid":false,"given":"Giordano","family":"Sigon","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-7213","authenticated-orcid":false,"given":"Paola","family":"Dongiovanni","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Vecchi","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"},{"name":"Unit of Gastroenterology and Endoscopy, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fargion","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ludovica","family":"Fracanzani","sequence":"additional","affiliation":[{"name":"Unit of Internal Medicine and Metabolic Disease, Fondazione Ca\u2019 Granda IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Trenell","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"Friedman","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cgh.2018.07.006","article-title":"Obesity and Weight Gain Are Associated with Progression of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease","volume":"17","author":"Kim","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/oby.21868","article-title":"Diet Quality in Midadulthood Predicts Visceral Adiposity and Liver Fatness in Older Ages: The Multiethnic Cohort Study","volume":"25","author":"Maskarinec","year":"2017","journal-title":"Obesity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.gastro.2018.03.038","article-title":"Improved Diet Quality Associates with Reduction in Liver Fat, Particularly in Individuals with High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease","volume":"155","author":"Ma","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of Distinct Lifestyle Interventions on Mobilization of Fat","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mazzocchi, A., Leone, L., Agostoni, C., and Pali-Sch\u00f6ll, I. (2019). The Secrets of the Mediterranean Diet. Does [Only] Olive Oil Matter?. Nutrients, 11.","DOI":"10.3390\/nu11122941"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09637486.2016.1214239","article-title":"Mediterranean diet and nonalcoholic fatty liver disease: Molecular mechanisms of protection","volume":"68","author":"Godos","year":"2017","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/hep.27544","article-title":"Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study","volume":"61","author":"Oh","year":"2015","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss","volume":"60","author":"Hallsworth","year":"2011","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ajg.2010.488","article-title":"Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease","volume":"106","author":"Kistler","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/liv.12552","article-title":"Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance","volume":"35","author":"Kwak","year":"2015","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2015.07.010","article-title":"Relationship of sitting time and physical activity with non-alcoholic fatty liver disease","volume":"63","author":"Ryu","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_25","first-page":"CD013574","article-title":"Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review","volume":"9","author":"Mayr","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bogataj Jontez, N., Novak, K., Kenig, S., Petelin, A., Jenko Pra\u017enikar, Z., and Mohorko, N. (2021). The Impact of COVID-19-Related Lockdown on Diet and Serum Markers in Healthy Adults. Nutrients, 13.","DOI":"10.3390\/nu13041082"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Scarmozzino, F., and Visioli, F. (2020). COVID-19 and the Subsequent Lockdown Modified Dietary Habits of Almost Half the Population in an Italian Sample. Foods, 9.","DOI":"10.3390\/foods9050675"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.orcp.2020.05.004","article-title":"Self-quarantine and weight gain related risk factors during the COVID-19 pandemic","volume":"14","author":"Zachary","year":"2020","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00592-020-01637-y","article-title":"Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: A single-centre observational study","volume":"58","author":"Biancalana","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.dsx.2020.08.012","article-title":"Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India","volume":"14","author":"Khare","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"108840","DOI":"10.1016\/j.diabres.2021.108840","article-title":"Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown","volume":"176","author":"Tanji","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_33","first-page":"3S","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"19","author":"Williams","year":"2018","journal-title":"G. Ital. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2014). Standards of medical care in diabetes\u20142014. Diabetes Care, 11, S14\u2013S80.","DOI":"10.2337\/dc14-S014"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.25548","article-title":"Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease","volume":"55","author":"Sullivan","year":"2012","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.28132","article-title":"Physical activity and liver diseases","volume":"63","author":"Berzigotti","year":"2016","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamainternmed.2016.3202","article-title":"Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"176","author":"Zhang","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pellegrini, M., Ponzo, V., Rosato, R., Scumaci, E., Goitre, I., Benso, A., Belcastro, S., Crespi, C., De Michieli, F., and Ghigo, E. (2020). Changes in Weight and Nutritional Habits in Adults with Obesity during the \u201cLockdown\u201d Period Caused by the COVID-19 Virus Emergency. Nutrients, 12.","DOI":"10.3390\/nu12072016"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e002035","DOI":"10.1136\/bmjdrc-2020-002035","article-title":"Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic","volume":"9","author":"Ruissen","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.pcd.2021.01.003","article-title":"Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people","volume":"15","author":"Karatas","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e13597","DOI":"10.1111\/eci.13597","article-title":"Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver","volume":"51","author":"Shanmugam","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1194\/jlr.M600185-JLR200","article-title":"Characterization of the human patatin-like phospholipase family","volume":"47","author":"Wilson","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12998\/wjcc.v6.i8.167","article-title":"PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease","volume":"6","author":"Wang","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/liv.13222","article-title":"Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression","volume":"37","author":"Wieser","year":"2017","journal-title":"Liver Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","article-title":"Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption","volume":"92","author":"Davis","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Yanai, H., and Yoshida, H. (2019). Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051190"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Valenti, L., Rametta, R., Ruscica, M., Dongiovanni, P., Steffani, L., Motta, B.M., Canavesi, E., Fracanzani, A.L., Mozzi, E., and Roviaro, G. (2012). The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-111"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jgh.12656","article-title":"PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease","volume":"30","author":"Shen","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000441185","article-title":"Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study","volume":"93","author":"Krawczyk","year":"2016","journal-title":"Digestion"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4103\/jfmpc.jfmpc_1896_20","article-title":"Effect of COVID 19 Lockdown on glycemic parameters in people with type 2 diabetes","volume":"10","author":"Tewari","year":"2021","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.jhepr.2020.100113","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.dld.2021.06.032","article-title":"Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO)","volume":"53","author":"Costantino","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"723790","DOI":"10.3389\/fmed.2021.723790","article-title":"Effects of Telemedicine on Obese Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"8","author":"Saokaew","year":"2021","journal-title":"Front. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/556\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:09:00Z","timestamp":1760134140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["nu14030556"],"URL":"https:\/\/doi.org\/10.3390\/nu14030556","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}